PS-101

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Amino Sugars: 110
  - PS-101: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Naphthoquinones: 418
        PS-101: 1
- Quinones: 434
  - Naphthoquinones: 418
    - PS-101: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Naphthoquinones: 418
      - PS-101: 1

Experts

1.	An, Yun-Feng: 1 article (12/2013)
2.	Cai, Le-Jing: 1 article (12/2013)
3.	Chen, Zhen-Feng: 1 article (12/2013)
4.	Liang, Hong: 1 article (12/2013)
5.	Liu, Yan-Cheng: 1 article (12/2013)
6.	Peng, Yan: 1 article (12/2013)
7.	Wang, Yan-Fei: 1 article (12/2013)
8.	Zhang, Guo-Hai: 1 article (12/2013)
9.	Zhou, Yuan-Hua: 1 article (12/2013)

Related Diseases

1.	Lung Neoplasms (Lung Cancer) 12/15/2013 - "This study investigated the anticancer effect of a novel compound PS-101 in human lung cancer cells. " 12/15/2013 - "Taken together, these results suggest that PS-101 may be a potential candidate for cancer therapy against human lung cancer. "
2.	Stomach Neoplasms (Stomach Cancer) 12/15/2013 - "By phenotype screening, PS-101 exhibited highly selective inhibition in EGFR-overexpressed non-small cell lung cancer cells NCI-H460 and A549 while displaying no obvious toxicity to normal hepatic cell HL-7702, lung fibroblast cell WI-38, liver cancer cell BEL-7404 and gastric cancer cell MCG-803. "
3.	Neoplasms (Cancer) 12/15/2013 - "Taken together, these results suggest that PS-101 may be a potential candidate for cancer therapy against human lung cancer. "
4.	Liver Neoplasms (Liver Cancer) 12/15/2013 - "By phenotype screening, PS-101 exhibited highly selective inhibition in EGFR-overexpressed non-small cell lung cancer cells NCI-H460 and A549 while displaying no obvious toxicity to normal hepatic cell HL-7702, lung fibroblast cell WI-38, liver cancer cell BEL-7404 and gastric cancer cell MCG-803. "
5.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/15/2013 - "Novel compound PS-101 exhibits selective inhibition in non-small-cell lung cancer cell by blocking the EGFR-driven antiapoptotic pathway." 12/15/2013 - "By phenotype screening, PS-101 exhibited highly selective inhibition in EGFR-overexpressed non-small cell lung cancer cells NCI-H460 and A549 while displaying no obvious toxicity to normal hepatic cell HL-7702, lung fibroblast cell WI-38, liver cancer cell BEL-7404 and gastric cancer cell MCG-803. "

Related Therapies and Procedures

1.	Therapeutics